Mancosu, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 7.631
AS - Asia 3.969
EU - Europa 1.558
SA - Sud America 773
AF - Africa 191
Continente sconosciuto - Info sul continente non disponibili 106
OC - Oceania 18
Totale 14.246
Nazione #
US - Stati Uniti d'America 7.490
SG - Singapore 2.390
CN - Cina 642
BR - Brasile 625
VN - Vietnam 474
DE - Germania 347
IT - Italia 330
FI - Finlandia 216
IE - Irlanda 196
HK - Hong Kong 124
FR - Francia 116
NG - Nigeria 116
NL - Olanda 77
GB - Regno Unito 72
CA - Canada 69
IN - India 60
AR - Argentina 46
RU - Federazione Russa 39
SE - Svezia 38
BD - Bangladesh 36
TR - Turchia 36
EC - Ecuador 32
IQ - Iraq 32
MX - Messico 30
ID - Indonesia 22
CL - Cile 21
PK - Pakistan 20
IL - Israele 19
AT - Austria 18
ZA - Sudafrica 18
ES - Italia 17
PL - Polonia 17
SA - Arabia Saudita 17
BE - Belgio 16
AU - Australia 15
CO - Colombia 15
MA - Marocco 13
UA - Ucraina 12
VE - Venezuela 12
MY - Malesia 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
JP - Giappone 10
KZ - Kazakistan 10
DZ - Algeria 9
EG - Egitto 9
OM - Oman 9
JO - Giordania 8
NP - Nepal 8
PE - Perù 8
CR - Costa Rica 7
HN - Honduras 7
JM - Giamaica 7
KE - Kenya 7
PY - Paraguay 7
TN - Tunisia 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
LT - Lituania 5
PH - Filippine 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
NI - Nicaragua 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
GT - Guatemala 3
KR - Corea 3
PS - Palestinian Territory 3
UG - Uganda 3
BB - Barbados 2
BO - Bolivia 2
CH - Svizzera 2
EU - Europa 2
GD - Grenada 2
GR - Grecia 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 14.131
Città #
Dallas 1.102
Singapore 1.077
Wilmington 943
Chandler 742
Ashburn 395
San Mateo 361
The Dalles 328
Shanghai 254
Ann Arbor 253
Council Bluffs 232
Falkenstein 226
Helsinki 215
San Jose 205
Dublin 193
Leawood 173
Princeton 156
Lawrence 154
Beijing 146
Boardman 141
Ho Chi Minh City 137
Hanoi 124
Milan 121
Benin City 116
Fairfield 114
New York 114
Hong Kong 105
Woodbridge 87
Santa Clara 86
Paris 80
Amsterdam 65
São Paulo 58
Rome 54
Los Angeles 47
Seattle 41
Phoenix 39
London 31
Buffalo 30
San Diego 29
Toronto 25
Rio de Janeiro 23
Da Nang 22
Norwalk 22
Haiphong 20
Belo Horizonte 17
Columbus 17
Orem 17
Miami 16
Brussels 15
Kocaeli 15
Baghdad 14
Figino 14
Guayaquil 13
Mexico City 13
Chennai 12
Curitiba 12
Hillsboro 12
Philadelphia 12
Vienna 12
Biên Hòa 11
Chicago 11
Frankfurt am Main 11
Johannesburg 11
Montreal 11
Boos 10
Brooklyn 10
Campinas 10
Can Tho 10
Genoa 10
Tashkent 10
Brasília 9
Munich 9
Ninh Bình 9
Nuremberg 9
Porto Alegre 9
Quito 9
Redmond 9
Salvador 9
Tokyo 9
Des Moines 8
Dhaka 8
Fortaleza 8
Guarulhos 8
Houston 8
Lahore 8
Redwood City 8
San Francisco 8
Santiago 8
Thái Bình 8
Warsaw 8
Amman 7
Charlotte 7
Denver 7
Greenville 7
Hải Dương 7
Moscow 7
Palermo 7
Asunción 6
Bathurst 6
Bradenton 6
Goiânia 6
Totale 9.454
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 762
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 684
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 157
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 145
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 115
SALVAGE RADIOTHERAPY WITH VOLUMETRIC MODULATION ARC THERAPY AND HYPOFRACTIONATION FOR RECURRENT PROSTATE CANCER AFTER HIFU FAILURE 112
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 107
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 105
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 105
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 105
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 104
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 99
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 98
Early Surgical Experience with Minimally Invasive Percutaneous Approach for Patients with Metastatic Epidural Spinal Cord Compression (MESCC) to Poor Prognoses 94
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 93
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 92
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer 92
Deep learning and atlas-based models to streamline the segmentation workflow of total marrow and lymphoid irradiation 90
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 90
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 89
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival 88
VOLUMETRIC MODULATION ARC RADIOTHERAPY COMPARED WITH STATIC GANTRY INTENSITY-MODULATED RADIOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA TUMOR: A FEASIBILITY STUDY 88
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 88
Organs at risk in lung SBRT 87
CRITICAL APPRAISAL OF VOLUMETRIC MODULATED ARC THERAPY IN STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES TO ABDOMINAL LYMPH NODES 87
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case 87
Low dose total marrow/total lymphoid irradiation (TMI/TLI) instead of TBI induce full donor chimerism before T-replete haploidentical transplantation (TR-H). 86
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 85
Stereotactic Body Radiation Therapy (SBRT) for adrenal metastases A Feasibility Study of Advanced Techniques with Modulated Photons and Protons 85
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 84
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 84
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 83
MULTIMODAL APPROACH TO THE MANAGEMENT OF METASTATIC EPIDURAL SPINAL CORD COMPRESSION (MESCC) DUE TO SOLID TUMORS 83
PRECLINICAL ASSESSMENT OF VOLUMETRIC MODULATED ARC THERAPY FOR TOTAL MARROW IRRADIATION 83
What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients? 83
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 82
CLINICAL OUTCOME OF HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY FOR ABDOMINAL LYMPH NODE METASTASES 82
Surgery Followed by Radiotherapy for the Treatment of Metastatic Epidural Spinal Cord Compression From Breast Cancer 82
Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results 81
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 81
Re-irradiation of metastatic spinal cord compression: A feasibility study by volumetric-modulated arc radiotherapy for in-field recurrence creating a dosimetric hole on the central canal 81
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 80
SBRT Dose Escalation Phase II Study for Liver Metastases Using Volumetric Modulated Arc Therapy (VMAT-RapidArc) 80
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 79
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 78
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 78
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments 78
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 78
FIVE FRACTIONS LINAC BASED SBRT FOR LOW - INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY REPORT OF A PHASE II STUDY WITH FLATTENING FILTER FREE DELIVERY AND SPACE OAR 77
Is Stereotactic Body Radiation Therapy an Attractive Option for Unresectable Liver Metastases? A Preliminary Report From a Phase 2 Trial 77
Critical re-evaluation of a failure mode effect analysis in a radiation therapy department after ten years 77
Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy 76
Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions 76
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients 76
RapidPlan head and neck model: the objectives and possible clinical benefit. 76
MLC parameters evaluation in a RT-dedicated MC environment (PRIMO) from static fields to VMAT plans 76
Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc 75
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments 75
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 75
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 75
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 74
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 74
Evaluation of a radiotherapy-dedicated Monte Carlo environment in clinical VMAT plans. 74
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 74
Linac-based stereotactic body radiation therapy for low and intermediate-risk prostate cancer : Long-term results and factors predictive for outcome and toxicity 74
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study 74
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 73
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 73
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma Feasibility and tolerability in elderly and chemotherapy-ineligible patients 73
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia 73
Impact of C-11-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors 72
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 72
Role of SBRT with VMAT technique and FFF beams for lymph-node metastases in oligometastatic patients from genitourinary malignancies 72
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. 71
Total Marrow Irradiation: A Clinical Evaluation of a Volumetric Modulated Arc Therapy Technique 71
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 71
Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer 71
Development of an immobilization device for Total Marrow Irradiation 70
Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer 70
Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. 70
Hypofractionated Stereotactic Radiotherapy and Radiosurgery for the Treatment of Patients with Radioresistant Brain Metastases 70
Are pitch and roll compensations required in all pathologies? A data analysis of 2945 fractions. 69
MLC parameters from static fields to VMAT plans: an evaluation in a RT-dedicated MC environment (PRIMO) 69
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: Preliminary report of a phase II study 69
Study of the radioluminesence spectra of doped silica optical fibre dosimeters for stem effect removal 69
Influence of "radioresistant" histologies on SBRT outcome for lung metastases 69
Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer 68
Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy. 68
Phase III randomized trial comparing two modalities of RS for brain metastases: Gammaknife vs Linac 68
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy. 67
Hypofractionation with VMAT versus 3DCRT in Post-operative Patients with Prostate Cancer. 67
Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation. 67
Total monitor units influence on plan quality parameters in volumetric modulated arc therapy for breast case 67
Does deep inspiration breath hold reduce plan complexity? Multicentric experience of left breast cancer radiotherapy with volumetric modulated arc therapy 67
Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma 67
Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative Diseases 67
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy. 66
SBRT In Oligometastatic Ovarian Cancer: A Promising Therapeutic Approach 66
Lean-six-sigma methodology for improving quality in RT: the breast daily repositioning case 66
RapidArc AND IMRT FOR MALIGNANT PLEURAL MESOTHELIOMA COMPARISON AND FEASIBILITY STUDY 66
Totale 9.368
Categoria #
all - tutte 90.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022673 0 8 10 200 4 3 30 122 69 56 151 20
2022/20232.230 338 44 179 261 191 192 3 194 435 188 180 25
2023/20241.081 73 137 252 45 41 92 29 39 54 25 118 176
2024/20251.611 26 40 31 20 34 189 107 205 224 394 186 155
2025/20265.955 658 454 987 533 142 185 1.252 529 470 309 168 268
2026/2027950 448 502 0 0 0 0 0 0 0 0 0 0
Totale 14.246